Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14409
Articles
Company
Drug
Abbisko ABSK043 NSCLC Combo Shows 71% Disease Control at ESMO Asia
December 8, 2025
Company
Drug
Leads Biolabs LBL-034 Multiple-Myeloma ASH Data Shows 82% ORR
December 8, 2025
Company
Drug
Junshi Biosciences roconkibart psoriasis NMPA Acceptance
December 8, 2025
Company
Drug
CSPC SYH2069 GLP-1/GIP Dual Agonist Wins FDA Nod for Obesity
December 8, 2025
Company
Drug
Asieris APL-1401 Ulcerative-Colitis Phase 1b Data Positive
December 8, 2025
Company
Medical Device
Balance Medical ePTFE Pericardial-Membrane Gets NMPA Nod, Ends Import Reliance
December 8, 2025
Company
Deals
Shanghai Pharma X842 Deal Termination with Sinorda
December 8, 2025
Company
Drug
Weixikang Lidocaine-Tetracaine Cream NMPA Clinical Trial Approval
December 8, 2025
Company
Drug
Anke-Biotech PA3-17 CAR-T Pediatric Indication NMPA Accepted
December 8, 2025
Company
Deals
Mirxes XtalPi AI Platform Targets Asian GI Cancers
December 8, 2025
Company
Deals
Sirnaomics ChemPartner GalAhead Nucleic-Acid Deal
December 8, 2025
Policy / Regulatory
NHSA 2025 Drug Lists Add 114 Medical Insurance Drugs, 19 Commercial
December 8, 2025
1
2
…
209
210
211
212
213
…
1,200
1,201
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?